BIO-TECHNE Corp — Director's Dealing 2025

Aug 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2025-08-07

Reporting Person: HIGGINS JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-08-07	Common Stock	M	5040	$21.84	Acquired	65236	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-07	Stock Option (Right to Buy)	$21.84	M	5040	Disposed	2025-10-28	Common Stock (5040)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$25.3000	2026-10-26	Common Stock (15940)	15940	Direct
Stock Option (Right to Buy)	$31.2600	2027-10-26	Common Stock (12500)	12500	Direct
Stock Option (Right to Buy)	$44.9600	2028-10-25	Common Stock (7592)	7592	Direct
Stock Option (Right to Buy)	$50.4100	2029-10-24	Common Stock (8044)	8044	Direct
Stock Option (Right to Buy)	$63.9200	2030-10-29	Common Stock (6028)	6028	Direct
Stock Option (Right to Buy)	$128.8100	2031-10-28	Common Stock (2532)	2532	Direct
Stock Option (Right to Buy)	$73.9400	2032-10-27	Common Stock (3460)	3460	Direct
Stock Option (Right to Buy)	$61.5100	2033-10-26	Common Stock (3937)	3937	Direct
Stock Option (Right to Buy)	$68.3700	2034-10-24	Common Stock (3511)	3511	Direct

Footnotes

F1: The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.